F Boehm - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F Boehm

Showing results (81-90 of 86) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 86 results.

Journal of Medicinal Chemistry|January 20, 2006

Orally active purine-based inhibitors of the heat shock protein 90Marco A Biamonte, Jiandong Shi, Kevin Hong, et al.

Journal of Medicinal Chemistry|August 18, 2006

7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitorsLin Zhang, Junhua Fan, Khang Vu, et al.

The Journal of Allergy and Clinical Immunology|July 6, 2024

Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonistsJoshua Wollam, Michelle Solomon, Christiane Villescaz, et al.

Journal of Medicinal Chemistry|June 13, 2003

Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetesP Y Michellys, R J Ardecky, J H Chen, et al.

Journal of Medicinal Chemistry|September 4, 2012

EC144 is a potent inhibitor of the heat shock protein 90Jiandong Shi, Ryan Van de Water, Kevin Hong, et al.

Endocrinology|November 5, 2005

Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetesMark D Leibowitz, Robert J Ardecky, Marcus F Boehm, et al.

Pageof 9

Search research articles

Showing results (81-90 of 86) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 86 results.

Journal of Medicinal Chemistry|January 20, 2006

Orally active purine-based inhibitors of the heat shock protein 90Marco A Biamonte, Jiandong Shi, Kevin Hong, et al.

Journal of Medicinal Chemistry|August 18, 2006

7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitorsLin Zhang, Junhua Fan, Khang Vu, et al.

The Journal of Allergy and Clinical Immunology|July 6, 2024

Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonistsJoshua Wollam, Michelle Solomon, Christiane Villescaz, et al.

Journal of Medicinal Chemistry|June 13, 2003

Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetesP Y Michellys, R J Ardecky, J H Chen, et al.

Journal of Medicinal Chemistry|September 4, 2012

EC144 is a potent inhibitor of the heat shock protein 90Jiandong Shi, Ryan Van de Water, Kevin Hong, et al.

Endocrinology|November 5, 2005

Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetesMark D Leibowitz, Robert J Ardecky, Marcus F Boehm, et al.

Pageof 9